UPPSALA, Sweden -- Olink Holding AB (publ) (Nasdaq: OLK) (“Olink” or the “Company”), today announced the pricing of its initial public offering of 17,647,058 common shares in the form of American Depositary Shares (“ADSs”), including 4,411,764 ADSs to be sold by the selling shareholders, at a price to the public of $20.00 per ADS, with [...]

AMSBIO, in association with Nordmark Biochemicals, is now offering animal-free Collagenase and Neutral Protease enzymes, isolated from Clostridium histolyticum, for in vitro tissue dissociation leading to high yields of viable cells. Being animal-free, these enzymes are very safe and offer reduced regulatory hurdles for use in clinical applications. They are manufactured under GMP guidelines using a plant-based production [...]

INTEGRA Biosciences, international manufacturer of laboratory equipment with technical and manufacturing centers in Switzerland and the US, officially celebrated the expansion of its state-of-the-art facility in Hudson, NH, with a community ribbon cutting ceremony. The newly extended facilities will expand the company’s US presence to meet the growing demand for its laboratory liquid handling products, which have [...]

Somerset, NJ – LabVantage Solutions, Inc., the leading provider of laboratory informatics solutions and services, including purpose-built LIMS solutions that allow labs to go live faster and at a lower total cost, today announced the appointment of Mikael Hagstroem as Chief Executive Officer. Mr. Hagstroem brings LabVantage almost 30 years of experience as a pioneer and [...]

Achievement Demonstrates OpenEye’s Unparalleled Experience Helping Pharmaceutical and Biotechnology Customers Optimize Computing Workloads SANTA FE, N.M. – OpenEye Scientific, developer of the world’s only cloud-native molecular design platform, Orion,™ announced today that it is among the first of only a handful of companies globally that have achieved Amazon Web Services (AWS) High Performance Computing (HPC) Competency status. [...]

Multi-year agreement to expand commercial footprint with world-leading genomics platform and develop R&D to unlock the potential of multimodal health data Boston, MA, USA, Lausanne, SWITZERLAND, and Tokyo, JAPAN --- SOPHiA GENETICS SA (“SOPHiA GENETICS”), pioneer in Data-Driven Medicine, and Hitachi, Ltd. (TSE:6501, "Hitachi") today announced they have entered into a long-term collaboration agreement to bring [...]

Innovative qPCR platform simplifies molecular diagnostic workflows for infectious disease, oncology and COVID-19 testing CARLSBAD, Calif. -- Thermo Fisher Scientific today announced the completion of the U.S. Food and Drug Administration (FDA) listing for the Applied Biosystems QuantStudio 5 Dx Real-Time PCR System. The innovative product enables clinical laboratories and assay developers to meet testing demands and enhance [...]

Effectively doubles Bay Area facilities, with increased R&D space and newly opened Customer Experience Center SANTA CLARA, Calif. – Rebus Biosystems, Inc., a venture-backed Silicon Valley-based life science technology company creating revolutionary tools to enable spatial omics research without compromise, today announced the appointment of Neil Kennedy as Chief Commercial Officer (CCO) and Scott Kothlow as Chief Financial Officer (CFO). This news comes [...]

Multi-year study will use Congenica’s platform for rapid and accurate genomic analysis Sioux Falls, South Dakota, United States and Cambridge, UK – Sanford Health (‘Sanford’), a leading US-based healthcare delivery system provider and Congenica, the digital health company enabling rapid and accurate analysis of complex genomic data to transform peoples’ lives, today announce a genomics partnership focused on [...]

NEW YORK — Avista Capital Partners (“Avista”), a leading private equity firm focused exclusively on healthcare, today announced that it has signed a definitive agreement to invest in eMolecules (“eMolecules,” or the “Company”), a novel and fast-growing e-procurement platform for high-value chemicals and bioreagents used by the leading pharmaceutical companies in drug discovery. Financial terms [...]